168 related articles for article (PubMed ID: 34147099)
1. Adaptive planning based on single beam optimization in passive scattering carbon ion radiotherapy for patients with pancreatic cancer.
Li Y; Kubota Y; Okamoto M; Shiba S; Okazaki S; Matsui T; Tashiro M; Nakano T; Ohno T
Radiat Oncol; 2021 Jun; 16(1):111. PubMed ID: 34147099
[TBL] [Abstract][Full Text] [Related]
2. Robustness of daily dose for each beam angle and accumulated dose for inter-fractional anatomical changes in passive carbon-ion radiotherapy for pancreatic cancer: Bone matching versus tumor matching.
Kubota Y; Okamoto M; Shiba S; Okazaki S; Matsui T; Li Y; Itabashi Y; Sakai M; Kubo N; Tsuda K; Ohno T; Nakano T
Radiother Oncol; 2021 Apr; 157():85-92. PubMed ID: 33515667
[TBL] [Abstract][Full Text] [Related]
3. Comparison of carbon-ion passive and scanning irradiation for pancreatic cancer.
Shiomi M; Mori S; Shinoto M; Nakayama Y; Kamada T; Yamada S
Radiother Oncol; 2016 May; 119(2):326-30. PubMed ID: 27262617
[TBL] [Abstract][Full Text] [Related]
4. Accumulation of the delivered dose based on cone-beam CT and deformable image registration for non-small cell lung cancer treated with hypofractionated radiotherapy.
Wang B; Wang DQ; Lin MS; Lu SP; Zhang J; Chen L; Li QW; Cheng ZK; Liu FJ; Guo JY; Liu H; Qiu B
BMC Cancer; 2020 Nov; 20(1):1112. PubMed ID: 33198676
[TBL] [Abstract][Full Text] [Related]
5. Comparison between bone matching and marker matching for evaluation of intra- and inter-fractional changes in accumulated dose of carbon ion radiotherapy for hepatocellular carcinoma.
Kubota Y; Katoh H; Shibuya K; Shiba S; Abe S; Sakai M; Yuasa D; Tsuda K; Ohno T; Nakano T
Radiother Oncol; 2019 Aug; 137():77-82. PubMed ID: 31078014
[TBL] [Abstract][Full Text] [Related]
6. "Dose of the day" based on cone beam computed tomography and deformable image registration for lung cancer radiotherapy.
Yuan Z; Rong Y; Benedict SH; Daly ME; Qiu J; Yamamoto T
J Appl Clin Med Phys; 2020 Jan; 21(1):88-94. PubMed ID: 31816170
[TBL] [Abstract][Full Text] [Related]
7. Worst case optimization for interfractional motion mitigation in carbon ion therapy of pancreatic cancer.
Steitz J; Naumann P; Ulrich S; Haefner MF; Sterzing F; Oelfke U; Bangert M
Radiat Oncol; 2016 Oct; 11(1):134. PubMed ID: 27717378
[TBL] [Abstract][Full Text] [Related]
8. Determination of Deformable Image Registration Algorithms for Accumulating Dose in Carbon-ion Radiotherapy for Pancreatic Cancer.
Li Y; Kubota Y; Okamoto M; Shiba S; Okazaki S; Matsui T; Komatsu S; Ohno T
Anticancer Res; 2021 Feb; 41(2):835-843. PubMed ID: 33517289
[TBL] [Abstract][Full Text] [Related]
9. Robust Beam Selection Based on Water Equivalent Thickness Analysis in Passive Scattering Carbon-Ion Radiotherapy for Pancreatic Cancer.
Zhou Y; Sakai M; Li Y; Kubota Y; Okamoto M; Shiba S; Okazaki S; Matsui T; Ohno T
Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173985
[TBL] [Abstract][Full Text] [Related]
10. Four-dimensional treatment planning in layer-stacking boost irradiation for carbon-ion pancreatic therapy.
Mori S; Shinoto M; Yamada S
Radiother Oncol; 2014 May; 111(2):258-63. PubMed ID: 24746568
[TBL] [Abstract][Full Text] [Related]
11. Intrafractional dose variation and beam configuration in carbon ion radiotherapy for esophageal cancer.
Haefner MF; Sterzing F; Krug D; Koerber SA; Jaekel O; Debus J; Haertig MM
Radiat Oncol; 2016 Nov; 11(1):150. PubMed ID: 27846916
[TBL] [Abstract][Full Text] [Related]
12. Comparing the dosimetric impact of interfractional anatomical changes in photon, proton and carbon ion radiotherapy for pancreatic cancer patients.
Houweling AC; Crama K; Visser J; Fukata K; Rasch CR; Ohno T; Bel A; van der Horst A
Phys Med Biol; 2017 Apr; 62(8):3051-3064. PubMed ID: 28252445
[TBL] [Abstract][Full Text] [Related]
13. Variation in accumulated dose of volumetric-modulated arc therapy for pancreatic cancer due to different beam starting phases.
Sasaki M; Nakamura M; Mukumoto N; Goto Y; Ishihara Y; Nakata M; Sugimoto N; Mizowaki T
J Appl Clin Med Phys; 2019 Oct; 20(10):118-126. PubMed ID: 31539194
[TBL] [Abstract][Full Text] [Related]
14. The role of multiple anatomical scenarios in plan optimization for carbon ion radiotherapy of pancreatic cancer.
Molinelli S; Vai A; Russo S; Loap P; Meschini G; Paganelli C; Barcellini A; Vitolo V; Orlandi E; Ciocca M
Radiother Oncol; 2022 Nov; 176():1-8. PubMed ID: 36113776
[TBL] [Abstract][Full Text] [Related]
15. Full Monte Carlo-Based Biologic Treatment Plan Optimization System for Intensity Modulated Carbon Ion Therapy on Graphics Processing Unit.
Qin N; Shen C; Tsai MY; Pinto M; Tian Z; Dedes G; Pompos A; Jiang SB; Parodi K; Jia X
Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):235-243. PubMed ID: 29079118
[TBL] [Abstract][Full Text] [Related]
16. Dose assessment for patients with stage I non-small cell lung cancer receiving passive scattering carbon-ion radiotherapy using daily computed tomographic images: A prospective study.
Li Y; Kubota Y; Kubo N; Mizukami T; Sakai M; Kawamura H; Irie D; Okano N; Tsuda K; Matsumura A; Saitoh JI; Nakano T; Ohno T
Radiother Oncol; 2020 Mar; 144():224-230. PubMed ID: 32044421
[TBL] [Abstract][Full Text] [Related]
17. Planning strategies for inter-fractional robustness in pancreatic patients treated with scanned carbon therapy.
Batista V; Richter D; Combs SE; Jäkel O
Radiat Oncol; 2017 Jun; 12(1):94. PubMed ID: 28595643
[TBL] [Abstract][Full Text] [Related]
18. Technical Note: Predicting dose distribution with replacing stopping power ratio for inter-fractional motion and intra-fractional motion during carbon ion radiotherapy with passive irradiation method for stage I lung cancer.
Kubota Y; Sakai M; Tashiro M; Saitoh JI; Abe T; Ohno T; Nakano T
Med Phys; 2018 Jul; 45(7):3435-3441. PubMed ID: 29757472
[TBL] [Abstract][Full Text] [Related]
19. Potential Pitfalls of Diaphragm Structural Matching in Carbon-ion Radiotherapy for Pancreatic Cancer.
Itabashi Y; Kubota Y; Okamoto M; Tsuda K; Shiba S; Hoshino Y; Suto T; Ohno T; Nakano T
Anticancer Res; 2019 Aug; 39(8):4351-4356. PubMed ID: 31366529
[TBL] [Abstract][Full Text] [Related]
20. A Monte-Carlo study to assess the effect of 1.5 T magnetic fields on the overall robustness of pencil-beam scanning proton radiotherapy plans for prostate cancer.
Kurz C; Landry G; Resch AF; Dedes G; Kamp F; Ganswindt U; Belka C; Raaymakers BW; Parodi K
Phys Med Biol; 2017 Oct; 62(21):8470-8482. PubMed ID: 29047455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
